Latest filing published 18 Dec 2012 for Lineage Cell Therapeutics, Inc., €382k.
Insider track record
No signal scores available.
Greenway Partners L P: trading record in brief
All filings by Greenway Partners L P on record concern Lineage Cell Therapeutics, Inc. The record holds 10 filings, for trades running from 31 March 2008 to 14 December 2012.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 18 December 2012 came the latest disclosure, a transaction for €382k in Lineage Cell Therapeutics, Inc. Typically, a trade is published a median of 5 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Greenway Partners L P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 115,022 shares@ US$4.34Common Shares, no par valueSEC:0001209191-12-058490:0
- 280,000 shares@ US$4.77Common Shares, no par valueSEC:0001209191-12-039685:0
- 220,086 shares@ US$2.00Common Shares, no par valueSEC:0001209191-10-052255:0
- 136,103 sharesCommon Shares, no par valueSEC:0001209191-09-042011:0
- 7,000 sharesCommon Shares, no par valueSEC:0001209191-09-022119:0
- 191,163 sharesCommon Shares, no par valueSEC:0001209191-09-021815:0
- 248,082 sharesCommon Shares, no par valueSEC:0001209191-09-002329:0
- 10,405 sharesCommon Shares, no par valueSEC:0001209191-08-061991:0
- 60,000 sharesCommon Shares, no par valueSEC:0001209191-08-024494:0
9 of 9 declarations